CHAPEL HILL, N.C.--(BUSINESS WIRE)--Jan. 16, 2008--POZEN Inc.
(NASDAQ: POZN) announced today that William L. Hodges, the company's
chief financial officer, will present at the Wachovia Securities 2008
Small & Mid Cap Healthcare Conference on Wednesday, January 30, 2008
at 11:15 a.m. (ET) at the Langham Hotel in Boston. Mr. Hodges'
presentation will be webcast and archived on POZEN's home page at
POZEN is a pharmaceutical company committed to developing
therapeutic advancements for diseases with unmet medical needs where
it can improve efficacy, safety, and/or patient convenience. POZEN's
efforts are focused primarily on the development of pharmaceutical
products for the treatment of acute and chronic pain and other
pain-related conditions. POZEN has development and commercialization
alliances with GlaxoSmithKline for the proposed product candidate
Treximet(TM) which is currently under review by the United States Food
and Drug Administration for the acute treatment of migraine, and with
AstraZeneca for the proposed product candidate PN 400 for conditions
such as osteoarthritis and rheumatoid arthritis in patients who are at
risk for developing NSAID-associated gastric ulcers. The company's
common stock is traded on The Nasdaq Stock Market under the symbol
"POZN". For detailed company information, including copies of this and
other press releases, see POZEN's website: www.pozen.com.
CONTACT: POZEN Inc.
Bill Hodges, 919-913-1030
Chief Financial Officer
Fran Barsky, 919-913-1044
Director, Investor Relations
SOURCE: POZEN Inc.